THE UNIVERSITY OF TEXAS – HOUSTON MEDICAL SCHOOL
DEPARTMENT OF PSYCHIATRY AND BEHAVIORAL SCIENCES
LECTURE SERIES
FEBRUARY 2003
WHERE: MSI AUDITORIUM (except for
February 12)
TIME: 11:00 a.m. – 12:00 p.m.
February 5
SCOTT KOLLINS, Ph.D.
Assistant Professor
Department of Psychiatry
Duke University School of Medicine
“Current Issues in the Use of Stimulants for the Treatment of ADHD”
February 12
This lecture presented in collaboration with Baylor College
of Medicine
Location:
UT-Dental Branch Building
6516 M.D. Anderson Blvd.
Auditorium, room 207
11:00-12:00
JOHN THOMPSON, M.D.
Vice Chair: Adult Psychiatry
Director: Forensic Neuropsychiatry
Tulane University School of Medicine
“Malingering: Guidelines For Forensic Assessment”
February 19
FACULTY MEETING
(Psychiatry Department Faculty only)
11:00 a.m. - 12:00 p.m.
Location To Be Announced
February 26
JOEL STEINBERG, M.D.
Associate Professor
Department of Psychiatry and Behavioral Sciences
The University of Texas Health Science Center at Houston
“Event-Related Functional Magnetic Resonance Imaging”
OVERALL EDUCATIONAL OBJECTIVES:
The participants should be able to 1) identify and describe current research
and clinical practice advances in the fields of psychiatry, psychology
and other mental health care professions, and 2) Summarize social dynamics
and/or ethical issues related to mental health science research activities
and patient care.
TARGET AUDIENCE:
MDs (Psychiatrists), psychologists, nurses, social workers and other mental
health professionals.
ACCREDITATION:
The University of Texas Medical School at Houston is accredited by the
Accreditation Council for Continuing Medical Education to provide continuing
medical education for physicians.
CREDIT HOUR DESIGNATION:
The University of Texas-Houston Medical School designates this educational
activity for a maximum of one hour in category 1 credit towards the AMA
Physicians Recognition Award. Each physician should claim only those
hours of credit that he/she actually spent in the educational activity.
ACKNOWLEDGEMENT:
Grateful acknowledgement is made to AstraZeneca, Eli Lilly, GlaxoSmithKline,
Janssen, Pfizer, Solvay and Wyeth-Ayerst for their generous support of
this CME activity.